We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$6.44B
AUM Growth
+$1.57B
Cap. Flow
+$88.6M
Cap. Flow %
1.38%
Top 10 Hldgs %
67.63%
Holding
740
New
307
Increased
52
Reduced
98
Closed
260

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$93M
2
IMMU
Immunomedics Inc
IMMU
+$61.7M
3
TAK icon
Takeda Pharmaceutical
TAK
+$43.4M
4
SONY icon
Sony
SONY
+$34.6M
5
MSFT icon
Microsoft
MSFT
+$34.1M

Sector Composition

Rank Sector Weight
1 Technology 4.35%
2 Materials 3.77%
3 Financials 3.2%
4 Consumer Discretionary 2.23%
5 Healthcare 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPLTW
326
DELISTED
Katapult Holdings Warrant
KPLTW
$407K 0.01%
+116,727
New +$177K
DVA icon
327
DaVita
DVA
$15.5B
$404K 0.01%
+3,439
New +$350K
CERN
328
DELISTED
Cerner Corp
CERN
$404K 0.01%
+5,143
New +$381K
BLFS icon
329
BioLife Solutions
BLFS
$1.58B
$388K 0.01%
9,733
-4,171
-30% -$142K
WMK icon
330
Weis Markets
WMK
$1.91B
$388K 0.01%
8,113
-3,120
-28% -$150K
AWK icon
331
American Water Works
AWK
$27.1B
$383K 0.01%
+2,498
New +$385K
HSKA
332
DELISTED
Heska Corp
HSKA
$375K 0.01%
2,572
-1,103
-30% -$137K
TROW icon
333
T. Rowe Price
TROW
$26.1B
$369K 0.01%
+2,435
New +$348K
PKG icon
334
Packaging Corp of America
PKG
$22.6B
$368K 0.01%
+2,666
New +$336K
CTSH icon
335
Cognizant
CTSH
$23.9B
$367K 0.01%
4,480
+1,098
+32% +$83.6K
ABUS icon
336
Arbutus Biopharma
ABUS
$871M
$365K 0.01%
102,765
-5,147
-5% -$18K
HOLX
337
DELISTED
Hologic
HOLX
$354K 0.01%
+4,862
New +$343K
ABMD
338
DELISTED
Abiomed Inc
ABMD
$353K 0.01%
+1,089
New +$301K
LFC
339
DELISTED
China Life Insurance Company Ltd.
LFC
$352K 0.01%
31,875
-638,031
-95% -$7.3M
ESTA icon
340
Establishment Labs
ESTA
$2.73B
$348K 0.01%
9,250
-3,257
-26% -$85.8K
MDGL icon
341
Madrigal Pharmaceuticals
MDGL
$12.4B
$348K 0.01%
+3,130
New +$383K
PH icon
342
Parker-Hannifin
PH
$124B
$345K 0.01%
+1,266
New +$314K
UA icon
343
Under Armour Class C
UA
$2.99B
$341K 0.01%
+22,939
New +$307K
FRT icon
344
Federal Realty Investment Trust
FRT
$11B
$339K 0.01%
+3,988
New +$332K
PDCO
345
DELISTED
Patterson Companies, Inc.
PDCO
$321K 0.01%
+10,836
New +$307K
GWW icon
346
W.W. Grainger
GWW
$65.6B
$314K ﹤0.01%
+768
New +$302K
IQV icon
347
IQVIA
IQV
$39.7B
$306K ﹤0.01%
+1,706
New +$287K
GBLI icon
348
Global Indemnity Group
GBLI
$399M
$305K ﹤0.01%
10,655
-15,403
-59% -$392K
LCIDW
349
DELISTED
Lucid Group, Inc. Warrant
LCIDW
$304K ﹤0.01%
200,000
SLM icon
350
SLM Corp
SLM
$4.78B
$294K ﹤0.01%
+23,754
New +$250K

Similar funds

LMR Partners's Q4 2020 Portfolio in Review

As of Q4 2020, LMR Partners held 740 positions worth $6.44B, up 32% from $4.86B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

LMR Partners's Q4 2020 filing shows 307 new, 52 increased, 98 reduced and 260 closed positions. Its largest new stake was DuPont de Nemours: 2,417,087 shares worth $216M. The largest sale was Alibaba, an estimated $93M.

By sector, the portfolio is most concentrated in Technology at 4.3% of assets, down from 6% a quarter earlier, followed by Materials and Financials.

  • LMR Partners's largest Q4 2020 buy was DuPont de Nemours: 2,417,087 shares worth $216M.
  • LMR Partners added most to Liberty Media Corporation Series C Liberty SiriusXM Common Stock in Q4 2020, an estimated $24.7M increase.
  • LMR Partners's biggest Q4 2020 reduction was Alibaba, cutting an estimated $93M.
  • LMR Partners fully exited Immunomedics Inc in Q4 2020, selling an estimated $61.7M.
  • LMR Partners's ten largest holdings make up 68% of its $6.44B portfolio in Q4 2020.
  • LMR Partners opened 307 new positions and closed 260 in Q4 2020.
  • LMR Partners's portfolio value rose 32% quarter-over-quarter to $6.44B.

Based on LMR Partners's 13F filing for Q4 2020, filed 16 Feb 2021.